Rizatriptan Benzoate (Rizatriptan Benzoate) (Tablet) 5 mg/1

Rizatriptan benzoate 5 mg tablet is a prescription medication used for acute migraine relief. It belongs to the triptan class and works to reduce headache pain and associated symptoms. This fast-acting tablet helps manage migraine attacks when taken at the first sign of symptoms.

Strength

5 mg/1

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rizatriptan benzoate 5 mg tablets are used to treat acute migraine headaches in adults. They help relieve symptoms such as throbbing pain, nausea, and sensitivity to light or sound. This medication is not intended for preventive migraine treatment or cluster headaches. It works best when taken at the earliest sign of a migraine attack.

Side Effects

Rizatriptan benzoate 5 mg tablets may help reduce the intensity of migraine pain and shorten attack duration. Some users report relief from nausea, light sensitivity, and sound sensitivity associated with migraines. Effects typically begin within 30 minutes to 2 hours after taking the tablet. Individual responses may vary based on migraine severity and timing of dose.

Precautions & Warnings

Rizatriptan benzoate 5 mg tablets should be stored at room temperature away from moisture and heat. Keep this medication in its original packaging until use and out of reach of children. Avoid taking more than the prescribed dose. If you experience chest pain or tightness after taking this medication, seek medical attention promptly.

Avoid Interactions

Rizatriptan benzoate 5 mg tablets may interact with other migraine medications, particularly ergot derivatives or other triptans. Combining with certain antidepressants or MAO inhibitors could increase serotonin levels. Alcohol may worsen migraine symptoms or increase drowsiness. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

It is used to treat acute migraine headaches in adults.

Effects typically begin within 30 minutes to 2 hours after taking the tablet.

Consult your healthcare provider before combining with other migraine treatments.

No, it is intended for acute migraine relief, not prevention.

Avoid alcohol and other medications that may interact unless approved by your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.